Glaxo Sells Drug Rights to Novartis

GlaxoSmithKline is selling its remaining rights to a drug used in treating autoimmune diseases to Novartis for up to $1 billion, plus royalties.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news